Atlas Trials

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Clinical trial NCT00628095 · COMPLETED

Trial details

NCT number
NCT00628095
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Arthritis, Rheumatoid
Start date
2008-04-07
Primary completion
2009-02-04
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.